Literature DB >> 8780248

Rat calcium-sensing receptor is regulated by vitamin D but not by calcium.

A J Brown1, M Zhong, J Finch, C Ritter, R McCracken, J Morrissey, E Slatopolsky.   

Abstract

Parathyroid hormone (PTH) secretion is regulated by extracellular calcium acting through a cell surface calcium receptor (CaR). We have examined the potential regulation of the CaR in the parathyroid glands (PTG) and kidney by calcium and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3]. Rats fed vitamin D-deficient (-D) diets containing 0.02, 0.4, or 2.0% Ca had a wide range of serum ionized Ca (2.5-5.2 mg/dl) and PTH (22-590 pg/ml) concentrations. PTG CaR mRNA did not vary significantly with ionized calcium or PTH, indicating that hypocalcemia and hyperparathyroidism may not alter CaR expression. However, PTG CaR mRNA was 40% lower in the -D rats than in age-matched rats fed a vitamin D-replete (+D) diet (P < 0.002). Repletion of -D rats with 1,25-(OH)2D3 produced a dose-dependent increase in PTG CaR mRNA. Treatment of +D rats with 100 ng of 1,25-(OH)2D3 increased CaR mRNA by 33% (P < 0.05) and 54% (P < 0.002) in the PTG and by 89% (P < 0.02) and 91% (P < 0.02) in the kidney in two independent experiments. PTG CaR peaked at 16 h (150% of control, P < 0.05) after 1,25-(OH)2D3 administration but returned to normal by 24 h. This upregulation of CaR expression by 1,25-(OH)2D3 may be involved in the suppressive effects of vitamin D compounds on PTH secretion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8780248     DOI: 10.1152/ajprenal.1996.270.3.F454

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  Calcium receptor and regulation of parathyroid hormone secretion.

Authors:  E M Brown
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 3.  Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.

Authors:  Ogo I Egbuna; Edward M Brown
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

4.  The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism.

Authors:  J Fox; S H Lowe; R L Conklin; E F Nemeth
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

Review 5.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 6.  The regulation of parathyroid hormone secretion and synthesis.

Authors:  Rajiv Kumar; James R Thompson
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

Review 7.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28

8.  Modulation of aquaporin 2 expression in the kidney of young goats by changes in nitrogen intake.

Authors:  Kristin Elfers; Gerhard Breves; Alexandra S Muscher-Banse
Journal:  J Comp Physiol B       Date:  2014-08-06       Impact factor: 2.200

Review 9.  Hyperparathyroidism and malnutrition with severe vitamin D deficiency.

Authors:  Amit Agarwal; Sushil Kumar Gupta; Ranjith Sukumar
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.

Authors:  Kazuhiro Shiizaki; Ikuji Hatamura; Eiko Nakazawa; Manabu Ogura; Takahiro Masuda; Tadao Akizawa; Eiji Kusano
Journal:  Med Mol Morphol       Date:  2008-07-01       Impact factor: 2.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.